Showing results (341-350 of 938) with videos related to
Sort By:
Pageof 94
Brain Research|December 4, 2001
6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidaseG Kunikowska, P JennerAmerican Journal of Clinical Pathology|May 1, 1990
Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposureM Hoffman, P JennerEuropean Journal of Neurology|January 7, 2012
Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's diseaseO Gershanik, P JennerBrain : a Journal of Neurology|June 1, 1977
Ballistic movement overflow myoclonus a form of essential myoclonusM Hallett, D Chadwick, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Young onset Parkinson's diseaseN Quinn, P Critchley, C D MarsdenBrain Research|August 24, 1981
Behavior of the long-latency stretch reflex prior to voluntary movementM Hallett, M Bielawski, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
Dystonia as the major manifestation of Leigh's syndromeG Lera, K Bhatia, C D MarsdenPsychopharmacologia|December 31, 1975
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatumC Pycock, D Tarsy, C D MarsdenNeurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D MarsdenPageof 94